ADMA Biologics, Inc. (NASDAQ:ADMA) Q4 2020 Earnings Conference Call March 25, 2021 4:30 PM ET Company Participants Skyler Bloom - Director, Investor Relations and Corporate Strategy Adam Grossman - Founder, President and Chief Executive Officer Brian Lenz - Executive Vice President and Chief Financial Officer Conference Call Participants Anthony Petrone - Jefferies Elliot Wilbur - Raymond James Operator Good afternoon and welcome to the ADMA Biologics Fourth Quarter and Full Year 2020 Financial Results Conf ...

ADMA Biologics, Inc. (NASDAQ:ADMA) Q3 2020 Earnings Conference Call November 5, 2020 4:30 PM ET Company Participants Skyler Bloom – Director-Investor Relations and Corporate Strategy Adam Grossman – President and Chief Executive Officer Brian Lenz – Executive Vice President and Chief Financial Officer Conference Call Participants Anthony Petrone – Jefferies Elliot Wilbur – Raymond James Leland Gershell – Oppenheimer Boobalan Pachaiyappan – H. C. Wainwright Zach Weiner – Jefferies Operator Good afternoon, an ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________ to ________ Commission file number 001-36728 ADMA BIOLOGICS, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware 56-2590442 (Sta ...

ADMA Biologics, Inc. (NASDAQ:ADMA) Q2 2020 Results Earnings Conference Call August 5, 2020 4:30 PM ET Company Participants Michelle Pappanastos - Investor Relations, Argot Partners Adam Grossman - Founder, President and Chief Executive Officer Brian Lenz - Executive Vice President and Chief Financial Officer Conference Call Participants Anthony Petrone - Jefferies Elliot Wilbur - Raymond James Raghuram Selvaraju - H.C. Wainwright & Co. Leland Gershell - Oppenheimer & Co. Operator Good afternoon and welcome ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON , D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________ to ________ Commission file number 001-36728 ADMA BIOLOGICS, INC. (Exact Name of Registrant as Specified in Its Charter) | --- | --- | |------------- ...

Start Time: 16:30 January 1, 0000 5:13 PM ET ADMA Biologics, Inc. (NASDAQ:ADMA) Q1 2020 Earnings Conference Call May 06, 2020, 16:30 PM ET Company Participants Adam Grossman - Founder, President and CEO Brian Lenz - EVP and CFO Samuel Martin - Argot Partners Conference Call Participants Anthony Petrone - Jefferies Elliot Wilbur - Raymond James Operator Good afternoon, and welcome to the ADMA Biologics First Quarter 2020 Financial Results Conference call on Wednesday, May 6, 2020. At this time, all participa ...